intranasal trivalent influenza virus vaccine

· Advagene Biopharma Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for intranasal trivalent influenza virus vaccine, covering 2018-12-26 to 2018-12-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult [Phase 2]